Analysis of borderline oxacillin-resistant Staphylococcus aureus (BORSA) strains isolated in Tunisia

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3345-3348

  Maalej, Senda Mezghani ^a   Rhimi, Faouzia Mahjoubi ^a   Fines, Marguerite ^b   Mnif, Basma ^a   Leclercq, Roland ^b   Hammami, Adnene ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFOXITIN; CHLORAMPHENICOL; CLOXACILLIN; ERYTHROMYCIN; FOSFOMYCIN; GLYCOPEPTIDE; IMIPENEM; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PRISTINAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BORDERLINE OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS; BORDERLINE OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; ERMC GENE; MECA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TUNISIA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CEFOXITIN; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; OXACILLIN; PENICILLIN-BINDING PROTEINS; STAPHYLOCOCCAL INFECTIONS; TUNISIA;

STAPHYLOCOCCUS AUREUS;

EID: 84866439472     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01354-12     Document Type: Article

References (27)

1. Angot P, Vergnaud M, Auzou M, Leclercq R, Observatoire de Normandie du Pneumocoque. 2000. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 19:755-758.
2. Balslev U, Bremmelgaard A, Svejgaard E, Havstreym J, Westh H. 2005. An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit. Microb. Drug Resist. 11:78-81. (Pubitemid 40365850)
3. Bannerman TL, Hancock GA, Tenover FC, Miller JM. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
4. Chambers HF. 1997. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10: 781-791. (Pubitemid 27477734)
5. Chang SC, Hseih WC, Luh KT. 1995. Influence of β-lactamase inhibitors on the activity of oxacillin against methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 21:81-84.
6. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. Document M100-S20. CLSI, Wayne, PA.
7. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2010. Communiqué 2010. Société Française de Microbiologie, Paris, France. http://www.sfm.asso.fr/.
8. Croes S, et al. 2010. Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 16:979-985.
9. Cuny C, Layer F, Strommenger B, Witte W. 2011. Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PLoS One 6 :e24360. doi:10.1371/ journal.pone.0024360.
10. Felten A, Grandry B, Lagrange PH, Casin I. 2002. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J. Clin. Microbiol. 40:2766-2771. (Pubitemid 35284939)
11. Garcia-Alvarez L, et al. 2011. Methicillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect. Dis. 11:595-603.
12. Kernodle DS, Classen DC, Stratton CW, Kaiser AB. 1998. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J. Clin. Microbiol. 36:219-222. (Pubitemid 28047463)
13. Khorvash F, Mostafavizadeh K, Mobasherizadeh S. 2008. Frequency of mecA gene and borderline oxacillin-resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections. Pak. J. Biol. Sci. 11:1282-1285.
14. Kragh Thomsen M, et al. 2006. Clonal spread of Staphylococcus aureus with reduced susceptibility to oxacillin in a dermatological hospital unit. Acta Derm. Venereol. 86:230-234. (Pubitemid 43875209)
15. Leahy TR, et al. 2011. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis. Pediatr. Pulmonol. 46: 489-496.
16. Massidda O, Montanari MP, Mingoia M, Varaldo PE. 1996. Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillins. Antimicrob. Agents Chemother. 40:2769-2774. (Pubitemid 26404341)
17. McDougal LK, Thornsberry C. 1986. The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J. Clin. Microbiol. 23:832-839. (Pubitemid 16120603)
18. Montanari MP, Tonin E, Biavasco F, Varaldo PE. 1990. Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins. Antimicrob. Agents Chemother. 34:911-913. (Pubitemid 20142426)
19. Montanari MP, Massidda O, Mingoia M, Varaldo PE. 1996. Borderline susceptibility to methicillin in Staphylococcus aureus: a new mechanism of resistance? Microb. Drug Resist. 2:257-269.
20. Murakami K, et al. 1991. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29:2240-2244.
21. Nadarajah J, et al. 2006. Identification of different clonal complexes and diverse amino acid substitutions in penicillin-binding protein 2 (PBP2) associated with borderline oxacillin resistance in Canadian Staphylococcus aureus isolates. J. Med. Microbiol. 55:1675-1683. (Pubitemid 44902031)
22. Sierra-Madero JG, Knapp C, Karaffa C, Washington JA. 1988. Role of β-lactamase and different testing conditions in oxacillin-borderline- susceptible staphylococci. Antimicrob. Agents Chemother. 32:1754-1757.
23. Skinner S, Murray M, Walus T, Karlowsky JA. 2009. Failure of cloxacillin in treatment of a patient with borderline oxacillin-resistant Staphylococcus aureus endocarditis. J. Clin. Microbiol. 47:859-861.
24. Swenson JM, et al. 2007. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagn. Microbiol. Infect. Dis. 58:33-39. (Pubitemid 46695926)
25. Swenson JM, Tenover FC, the Cefoxitin Disk Study Group. 2005. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 43:3818-3823. (Pubitemid 41129667)
26. Thauvin-Eliopoulos C, Rice LB, Eliopoulos GM, Moellering RC. 1990. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by β-lactamase-hyperproducing Staphylococcus aureus. Antimicrob. Agents Chemother. 34:728-732. (Pubitemid 20142388)
27. Varaldo PE. 1993. The borderline methicillin-susceptible Staphylococcus aureus. J. Antimicrob. Chemother. 31:1-4.